Dimeric indole alkaloid compounds, preparation method thereof and use thereof in preparation of antibacterial drugs
A dimer indole biological and compound technology, applied in antibacterial drugs, organic chemistry, pharmaceutical formulations, etc., can solve the problems of unseen synthetic methods and reports of their applications
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] The preparation of embodiment 1 compound 1a:
[0037] (1) Dissolve 0.28g of ethylenediamine in 30ml of dichloromethane, add 0.47g of triethylamine, and dropwise add 1.50g of compound 2 (N,N'-di-Boc-N"-triflylguanidine dissolved in dichloromethane ). Stir the reaction at room temperature for 10-12h. Wash and extract 2 times with saturated sodium bicarbonate solution, wash and extract once with water and saturated saline respectively. The organic phase is dried with anhydrous sodium sulfate, filtered and concentrated, and the residue is passed through a silica gel column Chromatography (eluent: ethyl acetate: methanol: triethylamine (volume ratio) = 10:1:0.1) yielded compound 3a as a colorless oil.
[0038] (2) Compound 3a was dissolved in dichloromethane, and after adding aqueous sodium bicarbonate solution, cyanogen bromide dissolved in dichloromethane was added dropwise at zero degrees Celsius, then reacted and stirred at room temperature for 1-2h, and separated and ex...
Embodiment 2
[0043] The preparation of embodiment 2 compound 1b:
[0044] With reference to Example 1, ethylenediamine is replaced with 1,6-hexamethylenediamine in step (1). Compound 1b was obtained as a pale yellow oil.
[0045] 1 H NMR (400MHz, CD 3 OD)δ(ppm):7.54(d,1H,ArH),7.40(dd,2H,ArH),7.28(d,1H,ArH),7.23(s,1H,CH),7.13(t,1H,ArH ),7.07(t,1H,ArH),7.04(t,1H,ArH),7.02(t,1H,ArH),6.94(t,1H,ArH),6.73(s,1H,CH),4.36(s ,2H,CH 2 ), 4.14 (s,2H,CH 2 ), 3.79(t,2H,CH 2 ), 3.05(t,2H,CH 2 ), 1.52 (m,2H,CH 2 ), 1.43 (m,2H,CH 2 ), 1.27-1.21 (m,4H,CH 2 ).
Embodiment 3
[0046] The preparation of embodiment 3 compound 1c:
[0047] Referring to Example 1, ethylenediamine in step (1) was replaced with 1,5-pentanediamine, and indoleacetic acid in step (4) was replaced with 5-fluoro-indoleacetic acid. Compound 1c was obtained as a pale yellow oil.
[0048] 1 H NMR (400MHz, CD 3 OD)δ(ppm):7.34(d,1H,ArH),7.31(s,1H,CH),7.25(d,1H,ArH),7.23(d,1H,ArH),7.10(d,1H,ArH ),6.90(dd,1H,ArH),6.84(dd,1H,ArH),6.84(s,1H,CH),4.35(s,2H,CH 2 ), 4.12 (s,2H,CH 2 ), 3.82(t,2H,CH 2 ), 3.03(t,2H,CH 2 ), 1.58-1.48 (m,4H,CH 2 ), 1.31-1.27 (m,2H,CH 2 ).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


